Novel small molecule derivatives improve mitochondrial function in Huntington’s Disease, suggesting potential therapeutic avenues.
Mitochondrial dysfunction is one of the primary cellular conditions involved in developing Huntington's Disease (HD) pathophysiology. The accumulation of mutant huntingtins protein with abnormal PolyQ repeats resulted in the death...
No takes yet. Share an insight, caveat, or question.
Pradeep et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: